Axa’s Vectren Corporation VVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-31,380
Closed -$1.21M 1542
2015
Q2
$1.21M Sell
31,380
-107,638
-77% -$4.54M ﹤0.01% 925
2015
Q1
$6.14M Sell
139,018
-233,600
-63% -$10.7M 0.03% 534
2014
Q4
$17.2M Sell
372,618
-325,365
-47% -$14.3M 0.07% 288
2014
Q3
$27.8M Buy
697,983
+44,040
+7% +$1.77M 0.12% 213
2014
Q2
$27.8M Buy
653,943
+421,460
+181% +$16.8M 0.12% 210
2014
Q1
$9.16M Buy
232,483
+10,010
+4% +$370K 0.04% 402
2013
Q4
$7.9M Buy
222,473
+7,574
+4% +$261K 0.04% 421
2013
Q3
$7.17M Buy
214,899
+36,339
+20% +$1.25M 0.04% 436
2013
Q2
$6.04M Buy
+178,560
New +$6.32M 0.03% 448

Other funds holding VVC

Axa's VVC Position: Q3 2015 in Review

Axa sold out of Vectren Corporation (VVC) in Q3 2015, closing a stake of 31,380 shares — an estimated $1.21M sold.

Axa first reported a position in VVC in Q2 2013 and held it in 9 quarters. The position peaked at $27.8M in Q3 2014. 275 funds tracked by Wall St. Rank hold VVC as of Q3 2015.

  • Axa reported no remaining Vectren Corporation position as of Q3 2015 after selling out during the quarter.
  • Axa sold 31,380 Vectren Corporation shares in Q3 2015, an estimated $1.21M.
  • Axa first reported a position in Vectren Corporation in Q2 2013 and held it in 9 quarters.
  • Axa's Vectren Corporation position peaked at $27.8M in Q3 2014.
  • 275 funds tracked by Wall St. Rank held Vectren Corporation as of Q3 2015.

Based on Axa's 13F filing for Q3 2015, filed 13 Nov 2015.